4-Chloro-7-(2-β-C-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d] pyrimidine structure
|
Common Name | 4-Chloro-7-(2-β-C-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d] pyrimidine | ||
|---|---|---|---|---|
| CAS Number | 443642-33-9 | Molecular Weight | 299.71 | |
| Density | 1.7±0.1 g/cm3 | Boiling Point | 570.5±50.0 °C at 760 mmHg | |
| Molecular Formula | C12H14ClN3O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 298.9±30.1 °C | |
Use of 4-Chloro-7-(2-β-C-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d] pyrimidine4-Chloro-7-(2-β-C-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d] pyrimidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 4-chloro-7-[2-C-methyl-β-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidine |
|---|---|
| Synonym | More Synonyms |
| Description | 4-Chloro-7-(2-β-C-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d] pyrimidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.7±0.1 g/cm3 |
|---|---|
| Boiling Point | 570.5±50.0 °C at 760 mmHg |
| Molecular Formula | C12H14ClN3O4 |
| Molecular Weight | 299.71 |
| Flash Point | 298.9±30.1 °C |
| Exact Mass | 299.067291 |
| PSA | 100.63000 |
| LogP | 0.77 |
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
| Index of Refraction | 1.733 |
| InChIKey | YNVCLSAXHSBSTK-GAJNKVMBSA-N |
| SMILES | CC1(O)C(O)C(CO)OC1n1ccc2c(Cl)ncnc21 |
| 7H-Pyrrolo[2,3-d]pyrimidine, 4-chloro-7-(2-C-methyl-β-D-ribofuranosyl)- |
| 4-Chloro-7-(2-C-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine |
| 4-chloro-7-(2-c-methyl-b-d-ribofuranosyl)-7h-pyrrolo[2,3-d]pyrimidine |
| 4-chloro-7-(2-c-methyl-beta-d-ribofuranosyl)-7h-pyrrolo[2,3-d]pyrimidine |